Abstract Mast cell hyperplasia is observed in various inflammatory skin diseases. Although the pathogenesis of these conditions remains largely uninvestigated, it has been speculated that lesional mediators provide a favorable microenvironment for mast cell growth. We investigated the effect of an inflammatory cytokine, IL-1α, on mast cell growth in a mast cell/fibroblast coculture system. When mouse bone marrowderived cultured mast cells (BMMC) were cultured on a NIH/3T3 fibroblast monolayer, IL-1α stimulated mast cell proliferation. However, IL-1α did not stimulate 3 H-thymidine incorporation in BMMC in the absence of fibroblasts. Separation of BMMC from fibroblasts by a permeable micropore membrane reduced the effect of IL-1α. When BMMC were prepared from W/W v mice, which lack a functional c-kit, or when NIH/3T3 fibroblasts were substituted with Sl/Sl d -derived fibroblasts, which lack membranebound stem cell factor (SCF), a lower, but significant, effect of IL-1α was observed. Flow cytometric analysis revealed no enhancement of SCF expression on fibroblasts following stimulation with IL-1α. Neutralizing antibodies against IL-3, IL-4, IL-10, and nerve growth factor (NGF) showed no inhibition. On the other hand, indomethacin inhibited the effect of IL-1α, and prostaglandin E 2 induced mast cell growth in the cocultures. These results indicate that IL-1α stimulates mast cell growth by a fibroblast-dependent mechanism, in which SCF/c-kit interaction may participate in a major way. The mast cell growth activity induced by this cytokine can, at least in part, be attributed to prostaglandins. Inflammatory cytokines may thus contribute to mast cell hyperplasia in skin diseases.
Introduction
Mast cells release inflammatory chemical mediators, such as histamine, leukotrienes, and prostaglandins (PG), on IgE-mediated stimulation with specific allergen. Mast cells thus play a pivotal role in immediate hypersensitivity reactions. In addition, recent studies have revealed that mast cells produce a wide variety of cytokines, suggesting their active participation in the late-phase reaction and the chronic-stage of inflammation [1, 2] .
Mast cells are increased in a variety of inflammatory skin diseases, such as atopic dermatitis and contact dermatitis, and in actinically damaged skin [1] . Repeated topical application of antigens [3, 4] or phorbol-myristate-acetate [5] , or ultraviolet light irradiation [6] has been reported to induce an increase in mast cells along with skin inflammation. However, the pathogenesis of mast cell accumulation in these conditions remains largely uninvestigated.
Accumulation of mast cells can be attributed to several mechanisms, that is, ingress of mast cell precursors, attraction of surrounding mast cells, prolonged survival, and local proliferation. Mitosis of mast cells observed in contact dermatitis [7] and atopic dermatitis [8] suggests that local proliferation is a possible mechanism.
Mast cells originate from hematopoietic stem cells in the bone marrow and are distributed to the peripheral connective tissues in premature form. Mast cells proliferate or complete their differentiation in the tissue where they reside, depending on the tissue microenvironment. The mechanism of mast cell growth has been largely investigated in the murine system, and recent studies in humans have revealed substantial differences between the two species. In the murine system, IL-3 and stem cell factor (SCF) induce mast cell proliferation and IL-4 enhances the effect of these cytokines, while in humans, SCF is the only mast cell growth factor yet known, and IL-3 and IL-
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Interleukin-1α enhances mast cell growth by a fibroblast-dependent mechanism 4 have little effect. Thus, the results obtained in studies using murine mast cells cannot be simply applied to the human system. However, in both species stromal cells play an important role. Indeed, in mast cell/fibroblast coculture systems, mouse skin-derived fibroblasts maintain and induce differentiation of mast cells of mice [9] , as well as mast cells of humans [10, 11] .
In normal skin, mast cells are usually observed in the upper dermis, around blood vessels and nerves, and in inflammatory skin diseases mast cells are frequent in the superficial dermis [5, 12, 13] . These observations suggest that fibroblasts, a major cellular component of the dermis, play an important role also in vivo, and that this mast cellfibroblast interaction is affected by local inflammatory mediators.
In this investigation, we studied the effect of an inflammatory cytokine, IL-1α, on mast cell growth in a murine mast cell/fibroblast coculture system. In skin inflammation, IL-1α is produced by keratinocytes, as well as various infiltrating inflammatory cells, such as macrophages and lymphocytes. Therefore, our results contribute to the elucidation of the pathomechanism of mast cell hyperplasia in inflammatory skin diseases.
Materials and methods

Cytokines and antibodies
Recombinant murine IL-1α, IL-3, IL-4, IL-10, and SCF were purchased from R&D Systems (Minneapolis, Minn.). Mouse submaxillary gland-derived 2.5 S nerve growth factor (NGF) was purchased from Harbor Bio-Products (Norwood, Mass.) and Toyobo (Osaka, Japan). Goat antimouse IL-1α, IL-3 and IL-4 antibodies were purchased from R & D Systems, antimouse IL-10 antibody was purchased from Endogen (Cambridge, Mass), goat antimouse SCF was purchased from Santa Cruz Biotechnology (Santa Cruz, Calif.), and sheep anti-NGF was purchased from Chemicon International (Temecula, Calif.). Indomethacin and prostaglandin E 2 (PGE 2 ) were purchased from Sigma (St. Louis, Mo.).
Cells
Bone marrow-derived cultured mast cells (BMMC) were obtained by culturing bone marrow cells of 6-week-old male mice, WBB6F 1 -W/W v (W/W v ) and their normal littermates WBB6F 1 -+/+ (+/+) (Shizuoka Laboratory Animal Center, Shizuoka, Japan), as previously described [14, 15] . Briefly, bone marrow cells suspended at a density of 1 × 10 6 /ml in αMEM (Dainippon Pharmaceutical, Osaka, Japan) supplemented with 10% heat-inactivated (56°C, 30 min) fetal calf serum, 100 IU/ml penicillin G (Meiji Pharmaceutical Co., Tokyo, Japan) and 100 µg/ml streptomycin (Meiji) (complete αMEM) with 5 ng/ml IL-3 and 2 ng/ml IL-4 were cultured at 37°C in a humidified atmosphere of 5% CO 2 in air. Nonadherent cells were collected by centrifugation and resuspended in fresh medium every 7 days. After 4 weeks, more than 95% of the nonadherent cells stained positively with alcian blue.
NIH/3T3 fibroblasts (ATCC No. CRL1658) were maintained in complete αMEM at 37°C in a humidified atmosphere of 5% CO 2 in air. Mouse skin fibroblasts were prepared from the dermis of +/+ mice. Sl/Sl d -3T3 fibroblasts were kindly provided by Dr. Y. Kitamura (Department of Pathology, Osaka University Medical School, Osaka, Japan).
Coculture
Coculture of BMMC with NIH/3T3 fibroblasts was performed as described previously [15] with slight modification. Briefly, 2 × 10 4 NIH/3T3 fibroblasts suspended in 0.5 ml complete αMEM were seeded in each well of four-well multidishes (Nunc, Roskilde, Denmark). Upon reaching confluence, the medium was aspirated and 0.5 ml medium containing various concentrations of cytokines and 2-3 × 10 4 BMMC was added. The cells were cultured at 37°C in a humidified atmosphere containing 5% CO 2 . The cultures were fed with fresh medium every other day.
In one set of experiments, confluent monolayers of fibroblasts were incubated with 50 µg/ml mitomycin C (Kyowa Hakko Kogyo Co., Tokyo, Japan) at 37°C for 30 min. After thorough washing, pretreated monolayers were used for the coculture. In the preincubation experiment, confluent monolayers of fibroblasts were incubated with IL-1α for 6 h before use in the cocultures. In this experiment, BMMC and fibroblasts were cocultured for 3 days without a medium change.
Mast cell counting in coculture Adherent cells in the coculture wells were treated with phosphatebuffered saline (PBS) containing 0.1% (w/v) trypsin (Difco Laboratories, Detroit, Mich.) and 0.27 mM EDTA for 10 min at 37°C, followed by the addition of a one-tenth volume of fetal calf serum. The dispersed cells were washed twice with PBS and suspended in 1 ml PBS. The total number of the cells in the suspension was determined using a hemocytometer. Aliquots of cell suspensions were cytocentrifuged and the resulting cell preparations were stained with alcian blue after fixation with Carnoy's solution. The numbers of mast cells, regarded as alcian blue-positive cells, in cocultures were calculated using the following formula: number of mast cells/well = A × C/B, where A is the total number of cells in a well counted with the hemocytometer, B the total number of cells counted in a cytocentrifuge specimen, and C the number of alcian blue-positive cells in the same specimen.
Determination of histamine content in cocultures
Cultured cells in each coculture well were denatured by adding HClO 4 at a final concentration of 0.25 M, and insoluble proteins were precipitated by centrifugation at 10,000 g for 10 min. The histamine concentrations in the supernatants were assayed using an automated fluorometric-HPLC system (Tosoh Corporation, Tokyo, Japan) as previously described [16] .
Separation of mast cells from fibroblasts using micropore membrane Mast cells were cultured in the tissue culture inserts where they shared the same medium with NIH/3T3 fibroblasts, but separated by a 0.2-µm pore membrane (Anopore membrane, Nunc). Culture medium was added to both the inner and outer sides of the inserts, and BMMC were seeded into the inner side at the start of coculture. The culture medium of the outer side was replaced on days 2,and the incorporated radioactivity in the cells was assayed in a liquid scintillation counter (LSC5100; Aloka, Tokyo, Japan).
Flow cytometric analysis of SCF expression
Fibroblasts were detached from the culture flasks by incubation with PBS containing 5 mM EDTA. Harvested cells were washed and suspended in PBS containing 1% bovine serum albumin (BSA) and 0.1% sodium azide. After incubation with 10% normal donkey serum (Chemicon), cells were aliquoted and incubated with goat antimouse SCF antibody or normal goat IgG. Cells were stained with FITC-conjugated donkey antigoat IgG antibody and analyzed in a Becton Dickinson FACScaliber flow cytometer.
Statistics
For statistical analyses, a t-test and Bonferroni test were used to compare two groups and three groups or more, respectively.
Results
Enhancement of mast cell growth by IL-1α in the mast cell/fibroblast coculture system When BMMC prepared from +/+ mice were seeded on a confluent monolayer of NIH/3T3 fibroblasts, 44.7 ± 9.3% (mean ± SD, n = 8) of the BMMC adhered to the monolayer within 48 h in the control medium. IL-1α did not significantly alter the proportion of adherent BMMC: 30.2 ± 1.8% in the presence of 10 ng/ml IL-1α. But this cytokine induced proliferation of BMMC after coculture for 7 days in a dose-dependent manner (Fig. 1 A) and the total histamine content paralleled the mast cell numbers in the same experiments (Fig. 1 B) . When mast cells were cultured in the presence of 10 ng/ml IL-1α, their numbers increased in a time-dependent manner during the first 10 days in coculture (Fig. 1 C) also paralleling the total histamine content in these experiments (data not shown). These findings indicated that the total histamine content could serve as an indicator of mast cell numbers in the 7-day cocultures. The mast cell growth-enhancing effect of IL-1α was reduced by anti-IL-1α antibody (data not shown).
Direct effect of IL-1α on mast cell proliferation As IL-1α enhanced mast cell growth in the mast cell/fibroblast coculture system, we next examined whether this cytokine was able to stimulate mast cell proliferation directly. When mast cells were cultured without fibroblasts for 48 h, 3 H-thymidine incorporation in the last 12 h was 81 ± 10 cpm, 54 ± 7 cpm, and 7111 ± 598 cpm (mean ± SEM, n = 3), in the control medium, in medium containing 10 ng/ml IL-1α, and in medium containing 50 ng/ml of SCF, respectively. The effect of the cytokine was also evaluated by direct cell counting. When BMMC at 1 × 10 5 cells/well were cultured without fibroblasts, the mast cell numbers rapidly decreased and viable cells were fewer than 5 × 10 3 cells/well after 5 days even in the presence of IL-1α, whereas SCF induced substantial proliferation of mast cells: 1.6 × 10 5 ± 1.4 × 10 4 cells/well (mean ± SEM, n = 3) were observed after 5 days, in the same experiments. Therefore, IL-1α does not directly stimulate mast cell proliferation.
Preincubation of fibroblasts with IL-1α
As it has been suggested that IL-1α induces mast cell growth by a fibroblast-dependent mechanism, we then studied the effect of pretreatment of fibroblasts with IL-1α. Pretreatment of fibroblasts with 10 ng/ml IL-1α for Fig. 1 A-C Mast cell growth induced by IL-1α in the mast cell/fibroblast coculture system. BMMC prepared from WBB6F 1 -+/+ mice were seeded onto the confluent monolayer of NIH/3T3 fibroblasts and cultured in the presence of IL-1α or medium. A, B Cells were harvested on day 7 and mast cell numbers (A) and total histamine content (B) were measured. C Cells were cultured in the presence (closed circles) or absence (open squares) of IL-1α (10 ng/ml), and harvested at each time-point. The results are expressed as means ± SEM of quadruplicate cultures from a representative of four experiments for each study. *P < 0.05 versus medium control at each time point 6 h induced significantly larger mast cell numbers after 3 days: 27,281 ± 669 and 21,587 ± 1,110 cells/well (mean ± SEM, n = 3, P < 0.01) in the cocultures with IL-1α-treated fibroblasts and with control fibroblasts, respectively. This indicates that IL-1α stimulates fibroblasts to produce mast cell growth factor, and the simultaneous presence of IL-1α is not necessary for the activity of this fibroblastderived mast cell growth factor. On the other hand, the conditioned medium from fibroblasts stimulated with IL-1α for 24 h showed no mast cell growth activity in 3 H-thymidine incorporation experiments (data not shown).
To further characterize the interaction of mast cells and fibroblasts in the coculture system, we separated mast cells from fibroblasts using a micropore membrane which prevents cellular contact but allows diffusion of soluble mediators. Mast cell growth was observed even when mast cells were separated from fibroblasts, but the effect was significantly lower than that observed without the membrane (Fig. 2) . For efficient mast cell proliferation in this system, the mast cells should be located close to or in contact with the fibroblasts.
Effect of mitomycin C treatment of fibroblasts
It is possible that mast cell proliferation is merely the result of fibroblast proliferation, because fibroblasts can maintain mast cells in coculture [9] and IL-1α stimulates fibroblast proliferation [17] . In dose-response and timecourse experiments (those shown in Fig. 1 ), we found that IL-1α increased the mast cell number per fibroblast. This suggests that mast cell growth is not only due to fibroblast proliferation. To confirm this, we treated the monolayer fibroblasts with the cytostatic agent, mitomycin C, before their use in the coculture (Table 1) . The mitomycin C treatment blocked fibroblast proliferation, and there was no significant difference in fibroblast numbers after cytokine stimulation. However, mitomycin C treatment did not significantly alter mast cell numbers after the coculture, indicating that mast cell growth in this system is not necessarily related to fibroblast proliferation.
Involvement of SCF in IL-1α-induced mast cell growth in coculture
Fibroblasts constitutively produce the potent mast cell growth factors, SCF, predominantly in membrane-bound form [18] . SCF binds its receptor, c-kit product, on mast cells to stimulate proliferation. Littermates of +/+ mice, W/W v mice, have mutations in the tyrosine kinase domain of c-kit, and BMMC derived from W/W v mice do not proliferate in response to SCF. To examine whether the SCF/c-kit pathway mediated the IL-1α-stimulated mast cell growth, we used W/W v -derived BMMC in the coculture system (Fig. 3) . Although mast cell numbers and the histamine content after 7 days were lower than those observed with +/+ BMMC, IL-1α caused significant differences in mast cell numbers, in parallel with total histamine content, in W/W v BMMC/fibroblast cocultures.
The effect of IL-1α was also evaluated in the combination of +/+-derived BMMC and the fibroblasts derived from Sl/Sl d mice, which lack the membrane-bound form of SCF (Fig. 4) . Similar to its effects in the experiments with W/W v -derived BMMC, IL-1α caused a significant difference in histamine content with this cell combination, although the absolute content was much lower than that with NIH/3T3 fibroblasts.
As a partial involvement of SCF was indicated, we then assessed whether IL-1α could enhance SCF expression on fibroblasts by indirect immunofluorescence staining and flow cytometry. Although constitutive expression Table 1 Mitomycin C treatment of fibroblasts. Confluent monolayers of fibroblasts were incubated with 50 µg/ml mitomycin C or medium at 37°C for 30 min. After thorough washing, BMMC were seeded on the monolayers and cocultured in the presence of of SCF on fibroblasts was observed, the expression was not altered by the incubation of fibroblasts with 10 ng/ml IL-1α for 24 h (data not shown).
We also examined whether another mast cell growth factor, IL-3, or cofactors for mast cell growth, IL-4 and IL-10 [19, 20] , are involved in cytokine-stimulated mast cell growth. As shown in Table 2 , neutralizing antibodies against these factors did not inhibit mast cell growth induced by IL-1α in the cocultures. NGF has been reported to induce proliferation of BMMC and the development of connective tissue-type mast cells in cocultures in the presence of IL-3 [21] . However, NGF obtained from several companies failed to induce mast cell growth in the concentration range 1 pg/ml to 100 ng/ml in our system, in which IL-3 was not supplemented (data not shown).
Involvement of prostaglandin in cytokine-induced mast cell growth in the coculture
We used a cyclooxygenase inhibitor, indomethacin, to examine whether this enzyme and prostanoids are involved in cytokine-stimulated mast cell growth in coculture (Fig. 5) . Indomethacin significantly reduced the effect of IL-1α on both +/+ and W/W v BMMC. These results indicate that cyclooxygenases are involved in cytokine-induced mast cell growth in coculture, and prostanoids provide the mast cell growth activity produced by fibroblasts. Indeed, the addition of PGE 2 to the cocultures induced significant increases in mast cell numbers and total cellular histamine (Fig. 6 ).
Effect of IL-1α on growth of mast cells cultured on skin-derived fibroblasts
We examined whether IL-1α induces proliferation of BMMC cultured on skin-derived fibroblasts as well as on NIH/3T3 fibroblasts. Fibroblasts were prepared from the skin of +/+ mice, the strain from which the BMMC were prepared, and used in the cocultures. As shown in Fig. 7 , IL-1α induced an increase in total histamine content, which indicates an increase in mast cell numbers in 7-day cultures, in the same concentration range. The cytokine- Table 2 Neutralization experiments with antibodies against IL-3, IL-4, IL-10, and NGF. BMMC were cocultured with NIH/3T3 fibroblasts in the presence of 10 ng/ml of IL-1α, IL-4, IL-10 or NGF, or 5 ng/ml of IL-3 for 6 days. Each antibody was added at a final concentration of 10 µg/ml. Growth of BMMC was determined in terms of total cellular histamine (ng/well) and a growth index was calculated as follows: (growth index) = (histamine content in each coculture)/(histamine content in the control coculture without cytokine). The values are means ± SEM of the growth indexes obtained from three experiments performed in duplicate (ND not done) Fig. 4 Coculture of BMMC derived from WBB6F 1 -+/+ mice with Sl/Sl d -derived fibroblast monolayer. BMMC prepared from +/+ mice were cocultured with Sl/Sl d -derived fibroblasts in the presence of IL-1α (10 ng/ml), SCF (30 ng/ml), IL-3 (5 ng/ml) or IL-4 (2 ng/ml). Mast cell growth was determined in terms of total cellular histamine on day 7. The data are means ± SEM from three experiments performed in quadruplicate. *P < 0.05, **P < 0.01 versus medium control induced mast cell growth mechanism appeared also to be effective in the cocultures with dermal fibroblasts.
Discussion
In this study we demonstrated that the inflammatory cytokine, IL-1α, induced mast cell growth in a BMMC/fibroblast coculture system (Fig. 1) . The effect was observed not only in cocultures with NIH/3T3 fibroblasts, which are established from mouse embryo, but also in cocultures with skin-derived fibroblasts prepared from the same strain from which the BMMC were obtained (Fig.  7) . As IL-1α is produced by keratinocytes and infiltrating cells in inflammatory lesions, this cytokine-stimulated fibroblast-dependent mast cell growth mechanism may play a role in mast cell hyperplasia observed in chronic skin inflammation. IL-1α by itself does not stimulate mast cell proliferation directly, but stimulates fibroblasts to produce mast cell growth activity. The considerable reduction in mast cell growth following the separation of BMMC from fibroblasts by a micropore membrane (Fig. 2 ) and no effect of IL-1α-stimulated fibroblast conditioned medium suggest the importance of membrane-associated factor(s) in mast cell growth. Subsequent experiments using defective cell lines indicated the involvement of SCF, a well-characterized mast cell growth factor, which is constitutively produced by fibroblasts predominantly in the membranebound form [18] . The use of W/W v -derived BMMC (Fig. 3) or Sl/Sl d -derived fibroblasts (Fig. 4) in the cocultures resulted in lower mast cell numbers and/or histamine content after 7 days in the presence of IL-1α, suggesting a major role of the SCF/c-kit pathway in mast cell growth.
As mast cell growth was observed in the cocultures with mitomycin C-treated fibroblasts (Table 1) , mast cell growth is not simply induced by fibroblast proliferation and the consequent increase in SCF. However, flow cytometric analysis revealed that treatment with IL-1α induced no enhancement of SCF expression on the fibroblasts (data not shown). Although conflicting results have been reported concerning SCF expression on cytokinestimulated human umbilical vein endothelial cells [22] [23] [24] , our observations are in agreement with those of Heinrich et al. [25] , who found that SCF expression on human fibroblasts is not altered by IL-1α. Moreover, the cytokine induced a significant difference in mast cell numbers and/or histamine content in the cocultures with cells that had a defect in the SCF/c-kit pathway (Figs. 3 and 4) . These results indicate the presence of an additional pathway modulated by IL-1α.
Indomethacin inhibited cytokine-induced mast cell growth in the cocultures (Fig. 5) . This suggests that cyclooxygenase, the rate-limiting enzyme of prostanoid synthesis, is involved in the mast cell growth mechanism. Indeed a product of the cyclooxygenase pathway, PGE 2 , induced the growth of mast cells in the cocultures (Fig. 6) , indicating a probable role of prostanoids. IL-1α is known to stimulate PG synthesis by fibroblasts by inducing the Coculture of BMMC with skin-derived fibroblasts. BMMC obtained from WBB6F 1 -+/+ mice were cocultured on monolayers of skin-derived fibroblasts prepared from mice of the same strain in the presence of IL-1α or control medium for 7 days. Mast cell growth was determined in terms of total histamine content. The result of a representative of three experiments performed in duplicate is shown expression of cyclooxygenase-2 [26] . As indomethacin also inhibited the growth of W/W v -derived BMMC in the cocultures, it is likely that the cyclooxygenase pathway is the additional pathway modulated by IL-1α. On the other hand, neutralization experiments using antibodies against IL-3, IL-4, IL-10 and NGF, indicated that these factors and cofactors for mast cell growth are unlikely to be involved.
It is therefore suggested that mast cell growth activity induced by IL-1α in fibroblasts can, at least in part, be attributed to prostanoids, and that the signal conducted via the SCF/c-kit pathway is important for this cytokine-induced mast cell growth activity, and/or the SCF/c-kit interaction serves as adhesion molecules that keep mast cells in contact with or in close range of fibroblasts. Considering that the extracellular domain of c-kit expressed on W/W v -derived BMMC is intact and can serve as an adhesion molecule [27] , the SCF/c-kit-mediated signal seems to be essential for efficient fibroblast-dependent mast cell growth.
In time-course experiments ( Fig. 1 C) , the effect of IL-1α was observed only in the earlier time period. Although it remains to be clarified, this limitation could be attributed to the culture conditions, in which contact-inhibited fibroblast monolayers were continuously stimulated with a mitogenic cytokine, which might have affected the properties of the fibroblasts. Indeed, at the end of a 14-day coculture stimulated with a higher concentration of IL-1α, fibroblasts showed a tendency to easily detach from culture dishes.
Hu et al. [28] have reported that PGE is essential for the induction of IL-3-dependent mouse mast cells from spleen cells. The authors conclude that PGE acts on mast cell precursors, but not on committed immature mast cells. In humans, PGE 2 enhances mast cell differentiation from cord blood mononuclear cells by inhibiting the production of macrophage-derived GM-CSF, which induces the differentiation into the granulocyte-macrophage lineage [29] . Our results indicate that PGE 2 also enhanced the growth of differentiated mast cells in the coculture system. It has been reported that keratinocyte-derived IL-1α induces increased PGE 2 production from dermal fibroblasts in human keratinocyte/fibroblast cocultures [30] . It is therefore possible that IL-1α-induced PG synthesis is involved in mast cell growth in human skin.
In conclusion, our results indicate that inflammatory cytokines induce mast cell growth by a fibroblast-dependent mechanism. Data from the murine system might not exactly apply to humans, but our findings may lead to the elucidation of the pathogenesis of mast cell hyperplasia observed in inflammatory, not necessarily allergic, skin diseases.
